ratios for 5 pharmaceutical companies’ vis-à-vis the industry average for these ratios. 1. Debt-Equity ratio‚ 2. Current ratio‚ and 3. Interest coverage ratio The 5 companies analysed include: 1. Vivimed Labs 2. Anuh Pharma 3. Tonira Pharma 4. Lincoln Pharmaceuticals 5. Dishman Pharmaceuticals & Chemicals FACTS AND ASSUMPTIONS: As for the industry averages and industry best ratios‚ we have taken the BSE Healthcare index‚ and treated it as a representative of
Premium Pharmaceutical industry Pharmacology Pharmacy
CHAPTER: 1 INTRODUCTION History of Indian Pharma Industry The Pharmaceutical industry in India is the world ’s third-largest in terms of volume and stands 14th in terms of value. According to Department of Pharmaceuticals‚ Ministry of Chemicals and Fertilizers‚ the total turnover of India ’s pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion. While the domestic market was worth US$ 12.26 billion. Sale of all types of medicines in the country is expected to
Premium Pharmaceutical industry Pharmacology Generic drug
Table of Contents CHAPTER 01: COMPANY OVERVIEW 1.1 Introduction The flagship company of the Square group of industries‚ Square Pharmaceuticals Limited (SPL) is the largest pharmaceuticals company in Bangladesh. Founded in 1958 and headquartered in Dhaka‚ Bangladesh‚ SPL develops‚ manufactures and markets drugs for humans and the animal world. The company owns and operates modern pharmaceutical factories mainly in Bangladesh and also has a separate division to operate a modern chemical
Premium Pharmaceutical industry Pharmacology
Segmentation * Key Players in Pharma Industry * Market Drivers * Challenges for Pharma Industry * SWOT Analysis * References Introduction Indian Pharmaceutical Industry is one of the success stories of modern India. The wide ranging capabilities in the complex field of drug manufacture & technology has established India as one of the major producer of the Pharmaceuticals worldwide. De-licensing of the pharmaceutical industry gave freedom to Indian Pharma manufacturers to produce
Premium Pharmacology Pharmaceutical industry Generic drug
evade taxes by any chance v. Profit flies back to the home country 3. Define Subsidiary A unit plant or factory plant of the MNC that is usually located in LEDCs where costs are low (such as wages‚ land). 4. Why did N-Pharma open subsidiaries in Australia‚ Canada‚ Mexico‚ Chile‚ Vietnam‚ South Korea and New Zealand? i. Expansion for markets and proximity to the market ii. Vietnam‚
Premium Marketing Cash flow Stock market
Big‚ Bad Pharma: An Unnecessary Evil Big‚ Bad Pharma: An Unnecessary Evil Big Pharma‚ or the pharmaceutical industry’s giant corporations‚ have earned record profits‚ falsified clinical trial data and corrupted the healthcare industry according to many industry critics including a recent report posted on Globalresearch.ca.[1] The industry’s story parallels the history of other corporate monopolies such as Big Oil‚ the Railroad Industry‚ Big Agriculture‚ banking interests and other industrial giants
Premium Pharmacology Clinical trial Medicine
INTRODUCTION STATEMENT OF THE PROBLEM THE pharmaceutical market in India today is worth Rs.57206 crores up from Rs. 5000 crores in 1995*. It is one of the fastest growing markets with a growth rate of around 15%. India has a large number of Pharmaceutical companies which operate in an environment of high competition. The competition is even higher in a high generic market like in India where drugs are in fierce price competition. It is estimated that there are around 20‚000 pharmaceutical
Premium Physician Pharmacology Medicine
Glenmark Pharma Private Limited Case Study Introduction * The company is headquartered in Baroda. * Mr. Ranjit Deshmukh holds the position of the Vice President. * Plants set up in Tamilnadu‚ Hyderabad and Gurgaon. * Markets bulk and cancer drugs and formulations. * Strong sales force of 700 people‚ supervised by 85 sales managers. * Salespeople have to compete with multiple competitors in different markets. * Competitors are from local manufacturers to large multinationals
Premium Management Sales Maslow's hierarchy of needs
growing rapidly due to the capability of Indian players to produce cost-effective drugs with world class manufacturing facilities. Bulk drugs of all major therapeutic groups‚ requiring complicated manufacturing processes are now being produced in India. Pharma companies have developed Good Manufacturing Practices (GMP) compliant facilities for the production of different dosage forms. In addition‚ India’s long-established position as a preferred manufacturing location for multinational drug manufacturers
Premium Pharmaceutical industry Clinical trial Pharmacology
Scenario ((Projected Pharmaceutical Market‚ 2004-2009)) 2.2.3 New Product Launches underlie market growth 2.2.5 Key Opportunities 2.2.6 FDI in Indian pharma 2.2.7 Strategy and Trends 2.2.8 Research and Development 2.2.9 SWOT Analysis 2.2.10 Mergers and Acquisitions in Pharma 2.2.11 Good Opportunities for ‘big pharma’ References Chapter Three-Merger between Glaxo Wellcome Smithkline Beecham 3.1 Introduction 3.2 Merger rationale 3.2.1 Rapid advances in Science
Premium Mergers and acquisitions Pharmaceutical industry